Extracellular Vesicle-derived Biomarkers in Prostate Cancer Care: Opportunities and Challenges

2024-10-1

RNA ac4C modification in cancer: Unraveling multifaceted roles and promising therapeutic horizons

2024-10-1

Editorial Board

2024-10-1

Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies

2024-10-1

Single-cell RNA-seq reveals heterogeneity in metastatic renal cell carcinoma and effect of anti-angiogenesis therapy in the pancreas metastatic lesion

2024-10-1

6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells

2024-10-1

Enhanced cytokine signaling and ferroptosis defense interplay initiates obesity-associated pancreatic ductal adenocarcinoma

2024-10-1

Unveiling the veil of RNA binding protein phase separation in cancer biology and therapy

2024-10-1

Editorial Board

2024-9-13

Editorial Board

2024-9-11

Complement is increased in treatment resistant rectal cancer and modulates radioresistance.

2024-9-1

A Rigorous Multi-Laboratory Study of Known PDAC Biomarkers Identifies Increased Sensitivity and Specificity Over CA19-9 Alone

2024-9-1

Letter to the editor on ‘A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer’

2024-9-1

A Tumor-promotional Molecular Axis CircMAPKBP1/miR-17-3p/TGFβ2 Activates Autophagy Pathway to Drive Tongue Squamous Cell Carcinoma Cisplatin Chemoresistance

2024-9-1

Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas

2024-9-1

Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis

2024-9-1

The deubiquitinase OTUD5 stabilizes SLC7A11 to promote progression and reduce paclitaxel sensitivity in triple-negative breast cancer

2024-9-1

TGF-β-induced lncRNA TBUR1 promotes EMT and metastasis in lung adenocarcinoma via hnRNPC-mediated GRB2 mRNA stabilization

2024-9-1

Editorial Board

2024-9-1

Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: a single-center retrospective analysis

2024-9-1

Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer.

2024-9-1

MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer

2024-9-1

DNA Repair Status as a Guide for Pancreatic Ductal Adenocarcinoma Treatment, an Old View for a New Future.

2024-9-1

Platelets promote primary hepatocellular carcinoma metastasis through TGF-β1-mediated cancer cell autophagy

2024-9-1

Forkhead Box Protein FOXK1 Disrupts the Circadian Rhythm to Promote Breast Tumorigenesis in Response to Insulin Resistance

2024-9-1

Loss of Nrf2 aggravates ionizing radiation-induced intestinal injury by inhibiting the cGAS/STING pathway via Pirin

2024-9-1

Evaluation and integration of cell-free DNA signatures for detection of lung cancer

2024-9-1

MATR3 Promotes Liver Cancer Progression by Suppressing DHX58–Mediated Type I Interferon Response

2024-9-1

Rewired glutamate metabolism diminishes cytostatic action of L-asparaginase

2024-9-1

Macroautophagy/autophagy promotes resistance to KRASG12D-targeted therapy through glutathione synthesis

2024-9-1

Single-cell RNA sequencing of OSCC primary tumors and lymph nodes reveals distinct origin and phenotype of fibroblasts

2024-9-1

The role of Hippo/YAP1 in cancer-associated fibroblasts: literature review and future perspectives

2024-9-1

Immune Checkpoint Reprogramming via Sequential Nucleic Acid Delivery Strategy Optimizes Systemic Immune Responses for Gastrointestinal Cancer Immunotherapy

2024-9-1

Is tumor microenvironment important for targeted therapy in lung cancer?

2024-9-1

Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes

2024-9-1

Serotonylation in tumor-associated fibroblasts contributes to the tumor-promoting roles of serotonin in colorectal cancer

2024-9-1

ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance

2024-9-1

LncRNA SNHG1 facilitates colorectal cancer cells metastasis by recruiting HNRNPD protein to stabilize SERPINA3 mRNA

2024-9-1

Exploiting tumor mechanomedicine for lung cancer treatment

2024-9-1

Single-nucleus sequencing unveils heterogeneity in renal cell carcinomas microenvironment: insights into pathogenic origins and treatment-responsive cellular subgroups

2024-9-1

Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges

2024-9-1

WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis

2024-9-1

Hepatic stellate cells promote hepatocellular carcinoma development by regulating histone lactylation: novel insights from single-cell RNA sequencing and spatial transcriptomics analyses

2024-9-1

Enhanced desmosome assembly driven by acquired high-level desmoglein-2 promotes phenotypic plasticity and endocrine resistance in ER+ breast cancer

2024-9-1

Editorial Board

2024-9-1

Immune Checkpoint Inhibitors Rechallenge in Non-Small Cell Lung Cancer: Current Evidence and Future Directions

2024-9-1

Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells

2024-9-1

Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy

2024-9-1

Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs

2024-9-1

Clinical characteristics and risk stratification for late-onset herpes zoster following allogeneic hematopoietic stem cell transplantation

2024-8-30